Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats

Neuroscience Letters

Volumn 453, Issue 3, 2009, Pages 151-156

  Lee, Bombi ^a   Shim, Insop ^b   Lee, Hye Jung ^a   Yang, Young ^c   Hahm, Dae Hyun ^a  

^a Kyung Hee University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

Acupuncture; Corticosterone (CORT); Depression and anxiety like behavior; Hypothalamic pituitary adrenal (HPA) axis; Neuropeptide Y (NPY)

Indexed keywords

CORTICOSTERONE; NEUROPEPTIDE Y;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACUPUNCTURE THERAPY; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CORTICOSTERONE; DEPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MAZE LEARNING; NEUROPEPTIDE Y; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 61849167454     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.01.076     Document Type: Article

References (33)

1. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smith A.D., Powell J.F., and Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331 (1985) 172-175
2. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
3. Chen J., Briscomb D., Waterhouse E., and Canby A.M. An uncontrolled pilot study of HT7 for 'stress'. Acupunct. Med. 20 (2002) 73-74
4. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
5. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotrophin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Rev. 15 (1990) 71-100
6. Gjerris A., Widerlöv E., Werdelin L., and Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J. Psychiatry Neurosci. 17 (1992) 23-27
7. Heilig M., and Widerlöv E. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr. Scand. 82 (1990) 95-114 Review
8. Hill M.N., Brotto L.A., Lee T.T., and Gorzalka B.B. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 905-911
9. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17 (1996) 187-205
10. Husum H., van Kammen D., Termeer E., Bolwig T.G., and Mathe A.A. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects. Neuropsychopharmacology 28 7 (2003) 1292-1299
11. Kim H.G., Lim E.Y., Jung W.R., Shin M.K., Ann E.S., and Kim K.L. Effects of treadmill exercise on hypoactivity of the hypothalamo-pituitary-adrenal axis induced by chronic administration of corticosterone in rats. Neurosci. Lett. 434 (2008) 46-49
12. Lee H.J., Lee B., Choi S.H., Hahm D.H., Kim M.R., Roh P.U., Pyun K.H., Golden G.T., Yang C.H., and Shim I. Electroacupuncture reduces stress-induced expression of c-fos in the brain of the rat. Am. J. Chin. Med. 32 (2004) 795-806
13. Lim S., Ryu Y.H., Kim S.T., Hong M.S., and Park H.J. Acupuncture increase neuropeptide Y expression in hippocampus of maternally-separated rats. Neurosci. Lett. 343 (2003) 49-52
14. Lowy M.T., Reder A.T., Antel J.P., and Meltzer H.Y. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am. J. Psychiat. 141 (1984) 1365-1370
15. Murray F., Smith D.W., and Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviors in mice. Eur. J. Pharmacol. 583 (2008) 115-127
16. Padovan C.M., and Guimaraes F.S. Restraint-induced hypoactivity in an elevated plus-maze. Braz. J. Med. Biol. Res. 33 (2000) 79-83
17. Pan B., Castro-Lopes J.M., and Coimbra A. Chemical sensory deafferentation abolishes hypothalamic pituitary activation induced by noxious stimulation or electroacupuncture but only decreases that caused by immobilization stress. Neuroscience 78 (1997) 1059-1068
18. Park H.J., Lee H.S., Lee H.J., Yoo Y.M., Lee H.J., Kim S.A., Leem K., Kim H.C., Seo J.C., Kim E.H., Lim S., and Chung J.H. Decrease of the electoracupuncture-induced analgesic effects in nucleus factor-kappa B1 knockout mice. Neurosci. Lett. 319 (2002) 141-144
19. Paxinos G., and Watson G. The Rat Brain in Stereotaxic Coordinates (1986), New York. Academic Press
20. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 15 (1978) 379-391
21. Redrobe J.P., Dumont Y., Fournier A., and Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26 (2002) 615-624
22. Sainsbury A., Rohner-Heanrenaud F., Cusin I., Zakrzewska K.E., Halban P.A., Gaillard R.C., and Jeanrenaud B. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40 (1997) 1269-1277
23. Sawchenko P.E., Swanson L.W., Grzanna R., Howe P.R.C., Bloom S.R., and Polak J.M. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J. Comp. Neurol. 241 (1985) 138-153
24. Serra M., Concas A., Mostallino M.C., Chessa M.F., Stomati M., Petraglia F., Genazzani A.R., and Biggio G. Antagonism of stress-induced changes in GABAA receptor function and corticotrophin-releasing factor concentration in rat brain. Psychoneuroendocrinology 24 (1999) 269-284
25. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J. Increased corticotrophin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur. J. Pharmacol. 28 (2000) 39-46
26. Stux G., and Pomeranz B. Acupuncture: Textbook and Atlas (1987), Springer-Verlag, Berlin
27. Sweerts B.W., Jarrott B., and Lawrence A.J. The effect of acute and chronic restraint on the central expression of prepro-neuro-peptide Y mRNA in normotensive and hypertensive rats. J. Neuroendocrinol. 13 (2001) 608-617
28. Thorsell A., Carlsson K., Ekman R., and Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 29 (1999) 3003-3007
29. Widerlov E., Heilig M., and Ekman R. Neuropeptide Y-possible involvement in depression and anxiety. In: Mutt V., Fuxe K., Hokfelt T., and Lundberg J.M. (Eds). Nobel Conference On NPY (1998), Raven Press, New York 331-342
30. Yang C.H., Lee B.B., Jung H.S., Shim I., Roh P.U., and Golden G.T. Effect of electroacupuncture on response to immobilization stress. Pharmacol. Biochem. Behav. 72 (2002) 847-855
31. Zhao R.J., Yoon S.S., Lee B.H., Kwon Y.K., Kim K.J., Shim I., Choi K.H., Kim M.R., Golden G.T., and Yang C.H. Acupuncture normalizes the release of accumbal dopamine during the withdrawal period and after ethanol challenge in chronic ethanol-treated rats. Neurosci. Lett. 395 (2006) 28-32
32. Zukowska-Grojec Z., and Neuropeptide Y. A novel sympathetic stress hormone and more. Ann. N.Y. Acad. Sci. 771 (1995) 219-233
33. Zurita A., Martijena I., Cuadra G., Brandao M.L., and Molina V. Early exposure to chronic variable stress facilitates the occurrence of anhedonia and enhanced emotional reactions to novel stressors: reversal by naltrexone pretreatment. Behav. Brain Res. 20 (2000) 163-171